23andMe Investor Day Presentation Deck

23ME'610 is an antibody against CD200R1 that can block CD200-mediated immune suppression CD200 is strongly expressed in a subset of human tumors CD200 immunohistochemistry (brown) shows expression on tumor cells Inhibiting CD200R1 signaling enhances anti- tumor immune responses 23ME'610 T APC Copyright © 2022 23and Me, Inc. 23and Me 22 22

View entire presentation